NPTX2 is decreased in the brain and CSF in AD, reflecting the loss of a key mechanism of synaptic homeostasis, whereas CSF Tau is increased, reflecting AD-related damage to neurons that may lead to regulated increases in the secretion of proteolytically cleaved Tau [34]. Here, MAPT is linked to Alzheimer disease.